This list is based on the watchlists of people on Stock Events who follow TG1N.STU. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Show more...
FAQ
What is Armata Pharmaceuticals stock price today?▼
The current price of TG1N.STU is €4.44 EUR — it has decreased by -3.9% in the past 24 hours. Watch Armata Pharmaceuticals stock price performance more closely on the chart.
What is Armata Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Armata Pharmaceuticals stocks are traded under the ticker TG1N.STU.
What is Armata Pharmaceuticals market cap?▼
Today Armata Pharmaceuticals has the market capitalization of 165.09M
When is the next Armata Pharmaceuticals earnings date?▼
Armata Pharmaceuticals is going to release the next earnings report on November 18, 2026.
What were Armata Pharmaceuticals earnings last quarter?▼
TG1N.STU earnings for the last quarter are -0.23 EUR per share, whereas the estimation was -0.39 EUR resulting in a +39.33% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Armata Pharmaceuticals revenue for the last year?▼
Armata Pharmaceuticals revenue for the last year amounts to 4.21M EUR.
What is Armata Pharmaceuticals net income for the last year?▼
TG1N.STU net income for the last year is -148.52M EUR.
How many employees does Armata Pharmaceuticals have?▼
As of September 10, 2026, the company has 61 employees.
In which sector is Armata Pharmaceuticals located?▼
Armata Pharmaceuticals operates in the Health & Wellness sector.
When did Armata Pharmaceuticals complete a stock split?▼
The last stock split for Armata Pharmaceuticals was on April 25, 2017 with a ratio of 1:10.
Where is Armata Pharmaceuticals headquartered?▼
Armata Pharmaceuticals is headquartered in LOS ANGELES, United States.